Can-Fite BioPharma (CANF) Return on Capital Employed [ROCE] (2013 - 2023)
Can-Fite BioPharma's Return on Capital Employed [ROCE] was -151.08% in FY2025, down 42.71 percentage points from -108.36% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Return on Capital Employed [ROCE] (2013 - 2023) Analysis & Trends
From FY2013 onward, Can-Fite BioPharma has reported Return on Capital Employed [ROCE] for 13 years.
- Return on Capital Employed [ROCE] has now declined for three consecutive years, though with a five-year change of +35.46 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Return on Capital Employed [ROCE] since FY2020.
- Per Business Quant data, Return on Capital Employed [ROCE] in earlier years was -108.36% in FY2024 (-0.76 pp), -107.60% in FY2023 (-40.79 pp), -66.81% in FY2022 (+38.82 pp) and -105.63% in FY2021 (+80.92 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Can-Fite BioPharma | 2.16 Mn | -17.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -108.41% |
| Sep 30, 2023 | -95.60% |
| Jun 30, 2023 | -82.28% |
| Mar 31, 2023 | -100.49% |
| Dec 31, 2022 | -96.50% |
| Sep 30, 2022 | -101.02% |
| Jun 30, 2022 | -84.69% |
| Mar 31, 2022 | -80.77% |
| Dec 31, 2021 | -87.27% |
| Sep 30, 2021 | -123.59% |
| Jun 30, 2021 | -128.06% |
| Mar 31, 2021 | -132.63% |
| Dec 31, 2020 | -142.52% |
| Sep 30, 2020 | -121.95% |
| Jun 30, 2020 | -195.29% |
| Dec 31, 2019 | -179.44% |
| Sep 30, 2019 | -103.29% |
| Jun 30, 2019 | -97.06% |
| Dec 31, 2018 | -86.35% |
| Sep 30, 2018 | -175.68% |
API Access
Can-Fite BioPharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();